These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2703383)
1. NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin. Panicucci R; Heal R; Laderoute K; Cowan D; McClelland RA; Rauth AM Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1039-43. PubMed ID: 2703383 [TBL] [Abstract][Full Text] [Related]
2. DNA-targeted 2-nitroimidazoles: studies of the influence of the phenanthridine-linked nitroimidazoles, 2-NLP-3 and 2-NLP-4, on DNA damage induced by ionizing radiation. Buchko GW; Weinfeld M Radiat Res; 2002 Sep; 158(3):302-10. PubMed ID: 12175307 [TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of a cell line resistant to 5-[3-(2-nitro-1-imidazoyl)-propyl]-phenanthridinium bromide (2-NLP-3), a DNA-intercalating hypoxic cell radiosensitizer and cytotoxin. Cowan DS; McClelland RA; Rauth AM Biochem Pharmacol; 1995 Jun; 50(1):61-8. PubMed ID: 7605346 [TBL] [Abstract][Full Text] [Related]
4. Targeting radiosensitizers to DNA by attachment of an intercalating group: nitroimidazole-linked phenanthridines. Cowan DS; Panicucci R; McClelland RA; Rauth AM Radiat Res; 1991 Jul; 127(1):81-9. PubMed ID: 2068275 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation. Cowan DS; Kanagasabapathy VM; McClelland RA; Rauth AM Int J Radiat Oncol Biol Phys; 1992; 22(3):541-4. PubMed ID: 1735693 [TBL] [Abstract][Full Text] [Related]
6. Radiosensitizing and cytotoxic properties of DNA targeted phenanthridine-linked nitroheterocycles of varying electron affinities. Cowan DS; Matejovic JF; Wardman P; McClelland RA; Rauth AM Int J Radiat Biol; 1994 Dec; 66(6):729-38. PubMed ID: 7814971 [TBL] [Abstract][Full Text] [Related]
7. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1. Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530 [TBL] [Abstract][Full Text] [Related]
9. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation. Denny WA; Roberts PB; Anderson RF; Brown JM; Phil D; Wilson WR Int J Radiat Oncol Biol Phys; 1992; 22(3):553-6. PubMed ID: 1735695 [TBL] [Abstract][Full Text] [Related]
10. Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds. Papadopoulou MV; Epperly MW; Shields DS; Bloomer WD Jpn J Cancer Res; 1992 Apr; 83(4):410-4. PubMed ID: 1506276 [TBL] [Abstract][Full Text] [Related]
11. KIH-802: 2-nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer. Hori H; Murayama C; Mori T; Shibamoto Y; Abe M; Onoyama Y; Inayama S Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1029-32. PubMed ID: 2703381 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro. Stratford IJ; Williamson C; Hardy C Br J Cancer; 1981 Jul; 44(1):109-16. PubMed ID: 7259957 [TBL] [Abstract][Full Text] [Related]
13. Iodoazomycin riboside (1-(5'-iodo-5'-deoxyribofuranosyl)-2-nitroimidazole), a hypoxic cell marker. I. Synthesis and in vitro characterization. Jette DC; Wiebe LI; Flanagan RJ; Lee J; Chapman JD Radiat Res; 1986 Feb; 105(2):169-79. PubMed ID: 3952269 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility. Hay MP; Lee HH; Wilson WR; Roberts PB; Denny WA J Med Chem; 1995 May; 38(11):1928-41. PubMed ID: 7783125 [TBL] [Abstract][Full Text] [Related]
16. DNA-targeted 2-nitroimidazoles: in vitro and in vivo studies. Cowan DS; Matejovic JF; McClelland RA; Rauth AM Br J Cancer; 1994 Dec; 70(6):1067-74. PubMed ID: 7981056 [TBL] [Abstract][Full Text] [Related]
17. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170. Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634 [TBL] [Abstract][Full Text] [Related]
18. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells]. Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162 [TBL] [Abstract][Full Text] [Related]
19. [Radiosensitizer: hypoxic cell radiosensitizer]. Mori T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001 [TBL] [Abstract][Full Text] [Related]
20. A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines. Suto MJ; Stier MA; Werbel LM; Arundel-Suto CM; Leopold WR; Elliott WE; Sebolt-Leopold JS J Med Chem; 1991 Aug; 34(8):2484-8. PubMed ID: 1875345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]